Shroom News,Spotlight Stock Levitee Labs Finalizes Acquisition of BlockMD Telemedicine By Dennis Mutua July 29, 2021 Functional mushroom company focusing on transforming the traditional landscape of mental health Levitee Labs Inc. (CSE: LVT) announced having closed the acquisition of BlockMD Ltd a leading telemedicine platform for patients with ...
Psychedelic Stocks,Shroom News MindCure Launches Second Stage of Producing Synthetic Ibogaine By Dennis Mutua July 28, 2021 Mental health and wellness company combining psychedelic research, technology, and medicine to optimize mental health care for patients and clinicians Mind Cure Health Inc. (CSE: MCUR) (OTCQB: MCURF) has launched second stage of ...
Psychedelic Stocks,Shroom News Wesana Health Set to Acquire PsyTech in a Deal Worth $21 Million By Dennis Mutua July 27, 2021 Life sciences company focusing on developing and delivering psychedelic-based therapies for brain injuries and neurological health issues Wesana Health Holding Inc. (CSE: WESA) is planning to acquire biotechnology company focusing...
Psychedelic Stocks,Shroom News Cybin Announces New York Stock Exchange Conditional Listing Approval By Dennis Mutua July 23, 2021 Biotechnology company focusing on progressing psychedelic therapeutics by utilizing drug discovery and delivery for various psychiatric and neurological conditions Cybin Inc. (NEO: CYBN) (OTCMKTS: CLXPF) announced having received ...
Psychedelic Stocks,Shroom News Small Pharma Launches a Psychedelic-Assisted Therapy Program By Dennis Mutua July 22, 2021 Neuropharmaceutical company developing novel rapid-acting treatments for depression and mental health conditions Small Pharma Inc. (TSXV: DMT) announced launching of psychedelics assisted therapy training program. The company h...
Psychedelic Stocks,Shroom News Levitee Labs To Start Trading on Canadian Securities Exchange By Dennis Mutua July 21, 2021 Emerging multidisciplinary integrative wellness company seeking to redefine mental healthcare through evidence-based medicines and novel psychedelics therapies Levitee Labs Inc. is set to start trading on the Canadian Securities E...
Psychedelic Stocks,Shroom News Octarine Bio Expands its Scientific Advisory Board By Dennis Mutua July 20, 2021 Sythentic biotechnology company developing biosynthetic platform to speed development of cannabinoid and psychedelic therapeutics Octarine Bio announced having expanded its scientific advisory board. This expansion entails addi...
Shroom News,Spotlight Stock Third Psychedelics Exchange-Traded Fund Set to be Launched Soon By Dennis Mutua July 19, 2021 A third psychedelics exchange-traded fund (ETF) is expected to be launched soon on the New York Stock Exchange Arca. This exchange-traded fund is set to be different from the others since it will be actively managed which will ...
